Nuwellis Inc (NUWE) Stock Analysis

Nuwellis Inc (NUWE) is a publicly traded company in the HEALTHCARE sector. It trades at $0.70, carries a market capitalization of $2.07M. This page summarizes the public market data, fundamentals, and frequently asked questions for NUWE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $0.70
• Market Cap: $2.07M
• EPS: $-26.89
• 52-Week High: $34.02
• 52-Week Low: $0.70

Market Sentiment

Nuwellis Inc currently has a Bearish sentiment score of -0.21.

About Nuwellis Inc

Nuwellis, Inc. is a trailblazing medical device company located in Eden Prairie, Minnesota, focused on addressing fluid overload through ultrafiltration therapy for patients with heart failure and kidney disease. The company's innovative, proprietary devices are designed to empower clinicians with effective therapeutic solutions, ultimately enhancing patient outcomes and quality of life. As the healthcare landscape increasingly prioritizes targeted and efficient treatment modalities, Nuwellis...

GNG Research Analysis

GNG Research scores Nuwellis Inc (NUWE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NUWE.

Frequently Asked Questions

Does NUWE pay dividends?

Nuwellis Inc (NUWE) does not currently pay a regular dividend.

What is NUWE's market cap?

Nuwellis Inc (NUWE) has a market capitalization of $2.07M with a current stock price of $0.70.